STAAR Surgical Company

Total Valuation

STAAR Surgical Company carries a market capitalization of 1.41B, placing it among publicly traded companies globally. Its enterprise value stands at 802.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

STAAR Surgical Company currently has 49.78M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 3.20, and the price-to-book ratio stands at -6.53.

Enterprise Valuation

The EV/Sales ratio of 2.76 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 129.62 provides insight into valuation relative to core operating earnings.

Financial Position

STAAR Surgical Company maintains a current ratio of 5.12, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Taxes

Over the trailing twelve months, STAAR Surgical Company has paid 1.47M in income taxes, reflecting an effective tax rate of 89.37.

Stock Price Statistics

STAAR Surgical Company's stock has gained approximately 66.98058% over the past 52 weeks. The 50-day moving average sits at 27.68, while the 200-day moving average is 24.37.

Income Statement

Over the trailing twelve months, STAAR Surgical Company generated 290.38M in revenue and converted that into -21.03M in net income, yielding earnings per share of -0.42. EBITDA reached 14.74M, while operating income came in at 6.19M.

Balance Sheet

STAAR Surgical Company holds 163.89M in cash and equivalents against 37.29M in total debt, resulting in a net debt position of -131.86M. Total book value stands at -142.32M, with working capital of 251.40M providing operational flexibility.

Cash Flow

STAAR Surgical Company produced -50.19M in operating cash flow over the past twelve months. After subtracting -4.79M in capital expenditures, free cash flow totaled -54.99M - equivalent to -1.11 per share.

Margins

STAAR Surgical Company operates with a gross margin of 76.89, reflecting its pricing power and cost economics. The operating margin of 2.13 and net profit margin of -7.24 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

STAAR Surgical Company's most recent stock split took place on May 18, 1992 with a 2:1 split ratio.

Scores

STAAR Surgical Company posts an Altman Z-Score of 6.64, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.